Narrative ReviewsCOVID-19: a boon or a bane for the microbiologists
Section snippets
Why COVID-19 is a boon for microbiologists
The dictionary meaning of the word “boon” is something beneficial to a specific person, entity or cause. The most important point in favor of this thought process is the upliftment of the specialty. There occurred a tremendous up-gradation of the fraternity of microbiology in terms of learning, up gradation of skills, infrastructure, networking, opportunities for inter disciplinary collaboration & research opportunities. Over the past century, humanity has witnessed the emergence of numerous
Why COVID-19 is a bane for microbiologists, the flip side of the story
The vast specialty of medical microbiology is reduced to just ‘covidology’ in the last one year period. The staff, students & researchers of microbiology specialty are working major hours in COVID-19 diagnosis leaving their usual activities.
The concentric attention on COVID-19 has swept away all other major national control programs against infections which had gained momentum in the past few years. The long term impact of this neglect on major infectious diseases like TB including drug
Conclusions
To conclude, COVID-19 is neither a boon nor a bane to the medical microbiologists. A balanced approach to the current problem in hand without ignoring all other pre-existing challenges is the need of the hour. No investment in time, infrastructure or knowledge will go waste. Whatever we have learnt during the pandemic should help us perform better in future to make the world a better place to live. And many collateral effects which we have faced during COVID-19 may be mitigated by a responsible
CRediT authorship contribution statement
Vasanthapuram Ravi: Acquisition of data, analysis & interpretation of data, review & editing, final approval of the version. Arunaloke Chakrabarti: Acquisition of data, analysis & interpretation of data, review & editing, final approval of the version. Chand Wattal: Conception and design of the study, Supervision, Revising the article critically for important intellectual content, Review & editing, final approval of the version. Reena Raveendran: Acquisition of data, analysis & interpretation
Source of support & conflict of interest
None.
Disclaimer
The data presented here is an authentic reproduction of presentations received for E-Microcon. While every effort has been made to assure the information provided here is complete and accurate; the editors/IJMM cannot assume any responsibility for omissions, errors, misprinting, or ambiguity contained within this publication.
References (33)
- et al.
COVID-19 vaccine: a recent update in pipeline vaccines, their design and development strategies
Eur J Pharmacol
(2021) - et al.
Probability of a zoonotic spill over with seasonal variation
Infect Dis Model
(2021) - et al.
Tuberculosis in the era of COVID-19 in India
Diabetes Metab Syndr
(2020) TB control in India in the COVID era
Indian J Tubercul
(2021)- et al.
Bacterial co-infection and secondary infection in patients with COVID-19: a living rapid review and meta-analysis
Clin Microbiol Infect
(2020) - et al.
Bacterial and fungal coinfection among hospitalized patients with COVID-19: a retrospective cohort study in a UK secondary-care setting
Clin Microbiol Infect
(2020) - et al.
Impact of COVID-19 on laboratory professionals-A descriptive cross sectional survey at a clinical chemistry laboratory in a developing country
Ann Med Surg (Lond)
(2020) - et al.
Prevalence of asymptomatic SARS-CoV-2 infection : a narrative review
Ann Intern Med
(2020) Lessons in public (Mis)communication about the laboratory from the COVID-19 pandemic
J Clin Microbiol
(2021)- National Medical commission. Issued on 13/10/2020. Available at: https://www.nmc.org. [accessed on May 25,...